• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996年至2023年中国发热伴血小板减少综合征人际传播的流行病学特征

Epidemiological characteristics of human-to-human transmission of severe fever with thrombocytopenia syndrome in China from 1996 to 2023.

作者信息

Yuan Li, Tian Tingting, Li Aqian, Du Shanshan, Wang Shiwen, Li Dexin, Huang Xiaoxia, Li Jiandong

机构信息

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing, People's Republic of China.

出版信息

PLoS Negl Trop Dis. 2025 Jul 24;19(7):e0013283. doi: 10.1371/journal.pntd.0013283. eCollection 2025 Jul.

DOI:10.1371/journal.pntd.0013283
PMID:40705734
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12289063/
Abstract

BACKGROUND

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral disease transmitted mainly through the bite of Haemaphysalis longicornis, and can cause clusters through contact transmission, and its incidence shows a rising and spreading trend in China. This study aimed to analyze the occurrence process of human-to-human transmission clusters and provide evidence for effective implementation of interventions.

METHODS

Data about SFTS human-to-human transmission clusters were extracted from 42 published articles. R 4.4.1 and Microsoft Excel software were used to process and analyze the epidemiological and clinical data extracted.

RESULTS

37 clusters occurring from 1996 to 2023 were retrieved, of which 2 (5.41%) involved third-generation transmission, 7 (18.92%) involved 16 asymptomatic infections, and 9 (24.32%) involved 17 medical personnel. There were 37 index cases with a case fatality rate of 97.30%, 135 secondary cases with a case fatality rate of 12.40%, and an overall of 31.33%. The first treatment of the index case was mainly in primary medical institutions (24, 64.86%) and the most common symptoms were fever, fatigue and gastrointestinal symptoms. The index cases were distributed from March to October each year, the peak was from April to July, and the incubation period was 5-21 days, mostly in middle-aged and elderly farmers. Clusters were mainly distributed in Jiangsu Province (9 clusters), followed by Henan, Shandong and Zhejiang Provinces (6 clusters each). The clusters occurred mostly in the progress of care (72.97%), funeral (64.86%) and treatment of patients (24.32%), involving relatives (75.76%), medical workers (12.12%), villagers (9.85%) and morticians (2.27%). Almost all clusters were spread by contact with patients' blood and bloody secretions (97.30%).

CONCLUSIONS

SFTS human-to-human transmission clusters sometimes occur in China, with a high case fatality rate. It is necessary to strengthen public health education, and improve the early diagnosis and treatment ability of medical workers, to avoid nosocomial infection or family (community) transmission.

摘要

背景

发热伴血小板减少综合征(SFTS)是一种新出现的病毒性疾病,主要通过长角血蜱叮咬传播,可经接触传播引起聚集性发病,在我国其发病率呈上升和蔓延趋势。本研究旨在分析人传人聚集性发病的发生过程,为有效实施干预措施提供依据。

方法

从42篇已发表文章中提取SFTS人传人聚集性发病的数据。使用R 4.4.1和Microsoft Excel软件对提取的流行病学和临床数据进行处理与分析。

结果

检索到1996年至2023年发生的37起聚集性发病事件,其中2起(5.41%)涉及三代传播,7起(18.92%)涉及16例无症状感染者,9起(24.32%)涉及17名医务人员。有37例首例病例,病死率为97.30%;135例二代病例,病死率为12.40%,总体病死率为31.33%。首例病例首次就诊主要在基层医疗机构(24例,64.86%),最常见症状为发热、乏力和胃肠道症状。首例病例发病时间分布在每年3月至10月,高峰在4月至7月,潜伏期为5至21天,以中老年农民为主。聚集性发病主要分布在江苏省(9起),其次为河南、山东和浙江省(各6起)。聚集性发病大多发生在护理过程中(72.97%)、丧葬过程中(64.86%)和患者治疗过程中(24.32%),涉及亲属(75.76%)、医护人员(12.12%)、村民(9.85%)和殡仪人员(2.27%)。几乎所有聚集性发病均通过接触患者血液和血性分泌物传播(97.30%)。

结论

我国有时会发生SFTS人传人聚集性发病事件,病死率较高。有必要加强公众健康教育,提高医务人员的早期诊断和治疗能力,避免医院感染或家庭(社区)传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3839/12289063/68327681bc45/pntd.0013283.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3839/12289063/84aded1c1b22/pntd.0013283.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3839/12289063/68327681bc45/pntd.0013283.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3839/12289063/84aded1c1b22/pntd.0013283.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3839/12289063/68327681bc45/pntd.0013283.g002.jpg

相似文献

1
Epidemiological characteristics of human-to-human transmission of severe fever with thrombocytopenia syndrome in China from 1996 to 2023.1996年至2023年中国发热伴血小板减少综合征人际传播的流行病学特征
PLoS Negl Trop Dis. 2025 Jul 24;19(7):e0013283. doi: 10.1371/journal.pntd.0013283. eCollection 2025 Jul.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Sexual Harassment and Prevention Training性骚扰与预防培训
6
Fatal risk factors and the efficacy of glucocorticoid therapy in severe fever with thrombocytopenia syndrome: a multicenter retrospective cohort study.严重发热伴血小板减少综合征的致死危险因素及糖皮质激素治疗的疗效:一项多中心回顾性队列研究
Front Cell Infect Microbiol. 2025 May 8;15:1531880. doi: 10.3389/fcimb.2025.1531880. eCollection 2025.
7
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
8
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.重复使用伊维菌素进行疟疾控制的安全性和有效性(RIMDAMAL II):一项3期、双盲、安慰剂对照、整群随机、平行组试验。
Lancet Infect Dis. 2025 Jul;25(7):737-750. doi: 10.1016/S1473-3099(24)00751-5. Epub 2025 Feb 4.

本文引用的文献

1
Serologic evidence of human exposure to the severe fever with thrombocytopenia syndrome virus and associated viruses in Kenya.肯尼亚人群中严重发热伴血小板减少综合征病毒及相关病毒血清学证据
Infect Dis (Lond). 2024 Sep;56(9):776-782. doi: 10.1080/23744235.2024.2370965. Epub 2024 Jun 24.
2
Epidemiololgical and etiological analysis of two clusters of severe fever with thrombocytopenia syndrome.两起严重发热伴血小板减少综合征聚集性疫情的流行病学和病因学分析。
Yi Chuan. 2023 Nov 20;45(11):1062-1073. doi: 10.16288/j.yczz.23-176.
3
A person-to-person transmission cluster of severe fever with thrombocytopenia syndrome characterized by mixed viral infections with familial and nosocomial clustering.
以混合病毒感染为特征、具有家庭聚集性和医院聚集性的发热伴血小板减少综合征人传人传播聚集性病例。
Heliyon. 2024 Jan 13;10(2):e24502. doi: 10.1016/j.heliyon.2024.e24502. eCollection 2024 Jan 30.
4
[The epidemiology and pathogeny investigation of two clusters of severe fever with thrombocytopenia syndrome disease outbreaking in Henan Province, 2022].
Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Oct 6;57(10):1719-1724. doi: 10.3760/cma.j.cn112150-20221130-01162.
5
Analysis of severe fever with thrombocytopenia syndrome cluster in east China.分析华东地区严重发热伴血小板减少综合征聚集性疫情。
Virol J. 2023 Sep 1;20(1):199. doi: 10.1186/s12985-023-02155-3.
6
Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review).严重发热伴血小板减少综合征免疫发病机制概述(综述)。
Int J Mol Med. 2022 Sep;50(3). doi: 10.3892/ijmm.2022.5174. Epub 2022 Jul 20.
7
[Epidemiological characteristics of severe fever with thtrombocytopenia syndrome in China, 2011-2021].[2011 - 2021年中国发热伴血小板减少综合征的流行病学特征]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Jun 10;43(6):852-859. doi: 10.3760/cma.j.cn112338-20220325-00228.
8
Predisposing factors for person-to-person transmission of severe fever with thrombocytopenia syndrome bunyavirus.严重发热伴血小板减少综合征布尼亚病毒人际传播的易感因素。
J Hosp Infect. 2022 May;123:174-178. doi: 10.1016/j.jhin.2021.10.023. Epub 2021 Nov 9.
9
Characteristics of Three Person-to-Person Transmission Clusters of Severe Fever with Thrombocytopenia Syndrome in Southeastern China.中国东南部三起人传人严重发热伴血小板减少综合征病例群集的特征。
Am J Trop Med Hyg. 2021 Jul 12;105(3):794-800. doi: 10.4269/ajtmh.21-0366.
10
Epidemiological Characteristics of Severe Fever with Thrombocytopenia Syndrome from 2010 to 2019 in Mainland China.中国大陆 2010 年至 2019 年严重发热伴血小板减少综合征的流行病学特征。
Int J Environ Res Public Health. 2021 Mar 17;18(6):3092. doi: 10.3390/ijerph18063092.